
Department of State @StateDept
In our efforts to combat COVID-19 around the world, we will continue to invest in companies that have experience manufacturing mRNA vaccines, to help them expand capacity by an additional 1 billion doses per year. https://t.co/Yrp9bQBD7C — PolitiTweet.org